Abstract
Data on the prevalence of contraindications and conditions requiring precaution for the administration of P2Y12 inhibitors in real-life patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) are scarce. We performed detailed recording of contraindications
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
